EZH2 and diffuse large B-cell lymphoma: Gain of function mutations of EZH2 have been reported in several neoplasms, including DLBCL [3,5], leading to excessive H3K27me3, a repressive mark, and ultimately promoting decreased differentiation, dysregulated proliferation and lymphomagenesis [24].